We Presented at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022) cover image

We Presented at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022)

We are pleased to inform that we were presenting at the 15 TH Clinical Trial on Alzheimer’s Disease NOVEMBER 29- DECEMBER 2, 2022 (“CTAD 2022”).

OptoCeutics has successfully collaborated with its partners at Zealand University Hospital and the Technical University of Denmark since its conception in 2018 to complete their first clinical trials on the safety and feasibility of their 40 Hz gamma light stimulation device for Alzheimer’s disease (AD).

With results from the recently completed trial, “Study on Safety, Feasibility, and Neural Activation of Non-Invasive Light Therapy System” (“ALZLIGHT Pilot”, ClinicalTrials.gov Identifier: NCT04574921), OptoCeutics will be presenting at CTAD 2022.

The company will share data on the safety and feasibility of their gamma light stimulation device from the ALZLIGHT Pilot clinical trial.

Marcus Carstensen, technical director at OptoCeutics, says: “We are excited to finally share the safety and feasibility results for ALZLIGHT Pilot. Zealand University Hospital, the Technical University of Denmark, and OptoCeutics have spent a lot of time since 2018 on the ALZLIGHT clinical trial, while simultaneously certifying the light-based brain stimulation system as a Class I medical device under MDR”.

For further information, please contact: Marcus Schulz Carstensen, CTO
OptoCeutics ApS
+45 23 45 64 42
msc@optoceutics.com

768 524 OptoCeutics
WeShop - Premium WordPress & WooCommerce theme by Euthemians - powered by Greatives

John Smith

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas varius tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam hendrerit molestie. Mauris malesuada nisi sit amet.

WeShop - Premium WordPress & WooCommerce theme by Euthemians - powered by Greatives

John Smith

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas varius tortor nibh, sit amet tempor nibh finibus et. Aenean eu enim justo. Vestibulum aliquam hendrerit molestie. Mauris malesuada nisi sit amet.

OC logo gold

Get exclusive content straight from the scientists who are rooting for you and your brain.

    Be the first to know about new developments from your favorite products
    Optoceutics logo word mark blue

    Join our newsletter & get exclusive content from us.

    Stay connected to your brain’s biggest cheerleaders and never miss new studies, tips and advice from our panel of experts.

    OC logo gold

    Get exclusive content straight from the scientists who are rooting for you and your brain.

      Be the first to know about new developments from your favorite products
      Privacy Preferences

      When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

      Click to enable/disable Google Analytics tracking code.
      Click to enable/disable Google Fonts.
      Click to enable/disable Google Maps.
      Click to enable/disable video embeds.
      Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.